New podcast season to spotlight P&L-focused leaders blazing the trail to purposeful procurement ...
Q4 2025 earnings call recap: pipeline milestones, PROTAC FDA/PDUFA timeline, 2026 data catalysts, and cash runway—read now.
Asianet Newsable on MSN
Novavax Q4 earnings preview: Wall Street expects wider losses amid diversification efforts
According to data from Fiscal AI, Novavax is expected to report a quarterly loss per share of $0.55, higher than the loss of ...
Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.
As Chair of the Scientific Advisory Committee, Dr. Lewis-Hall will provide leadership in scientific, clinical, and regulatory governance across Helus' portfolio, advising on discovery opportunities, ...
R. Romp to its Board of Directors. Romp brings extensive oncology commercialization experience from senior roles at Seagen and Genentech. The appointment comes as Celcuity advances Gedatolisib in ...
Agreement worth up to $495 million is part of a growing number of Chinese deals with global pharma giants as the country advances from a role as follower to innovator ...
The CEO of healthcare-focused asset manager Bellevue Group sees the company on a path to recovery. Following the necessary ...
Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new–generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results